Evidence map›Paper›PMID 31662520›Full record

ArticleIn vivo (Athens, Greece)

Cumulus Cells Are Potential Candidates for Cell Therapy.

Eslam Essam Mohammed, Sema Yilmaz, Oya Alagoz Akcin, Barbaros Nalbantoglu, Cem Ficicioglu, Fikrettin Sahin, Esra Aydemir Coban

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Eslam Essam MohammedDepartment of Biochemistry, Yildiz Technical University, Istanbul, Turkey.
Sema YilmazDivision of Pediatric Hematology/Oncology, Health Science University Kartal Lutfi Kirdar Education and Research Hospital, Istanbul, Turkey.
Oya Alagoz AkcinDepartment of Gynecology and Obstetrics, Yeditepe University Faculty of Medicine, Istanbul, Turkey.
Barbaros NalbantogluDepartment of Biochemistry, Yildiz Technical University, Istanbul, Turkey.
Cem FiciciogluDepartment of Gynecology and Obstetrics, Yeditepe University Faculty of Medicine, Istanbul, Turkey.
Fikrettin SahinDepartment of Bioengineering and Genetics, Yeditepe University Faculty of Medicine, Istanbul, Turkey.
Esra Aydemir CobanDepartment of Bioengineering and Genetics, Yeditepe University Faculty of Medicine, Istanbul, Turkey esra.aydemir@yeditepe.edu.tr.
Yeditepe University · TRYıldız Technical University · TRDr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimCumulus cells (CCs) originate from the membrane granulosa cells and surround oocytes during follicle maturation. CCs produce high levels of hyaluronan that targets CD44, which is a major tumorigenic marker. This study aimed to investigate whether CCs have a role in cell therapy by targeting CD44 in pancreatic cancer cells. MATERIALS AND

methodsCCs were isolated from the oocytes and incubated in a hypoxic environment. BxPC-3 pancreatic cancer cells were treated with CC conditioned media for three days.

resultsConditioned media of CC cells incubated in hypoxic conditions caused a 25% reduction in the viability of BxPC-3 cells. Expression of anti-apoptotic genes was down-regulated, while that of pro-apoptotic genes was upregulated. An increased number of BxPC-3 cells exhibited increased levels of reactive oxygen species and arrested in the synthesis (S) phase of the cell cycle.

conclusionCCs conditioned medium induced apoptosis of pancreatic cancer cells.

Indexed as

ApoptosisBiomarkers, TumorCell- and Tissue-Based TherapyCell Line, TumorCumulus CellsDown-RegulationGene Expression ProfilingHumansHyaluronan ReceptorsOocytesPancreatic NeoplasmsBiomarkers, TumorHyaluronan ReceptorsBxPC-3granulosa cellsoocytepancreatic cancer

Identifiers

PMID31662520
PMCPMC6899107
OpenAlexW2987075193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.